Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022
Sign Up to like & getrecommendations! Published in 2022 at "Eurosurveillance"
DOI: 10.2807/1560-7917.es.2022.27.50.2200882
Abstract: Modified vaccinia virus Ankara vaccine (MVA-BN; Bavarian Nordic) is recommended to contacts of mpox cases up to 14 days post-exposure but the effectiveness of this strategy is unknown. Among 108 adults (≥ 18 years old) who received one… read more here.
Keywords: ankara; modified vaccinia; mpox cases; exposure ... See more keywords